147 related articles for article (PubMed ID: 9343288)
1. Tyrosinemia type III: diagnosis and ten-year follow-up.
Cerone R; Holme E; Schiaffino MC; Caruso U; Maritano L; Romano C
Acta Paediatr; 1997 Sep; 86(9):1013-5. PubMed ID: 9343288
[TBL] [Abstract][Full Text] [Related]
2. [Hereditary tyrosinemia type III].
Endo F
Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):137-40. PubMed ID: 9590008
[No Abstract] [Full Text] [Related]
3. Dietary treatment of tyrosinemia type I: importance of methionine restriction.
Michals K; Matolon R; Wong PW
J Am Diet Assoc; 1978 Nov; 73(5):507-14. PubMed ID: 701680
[TBL] [Abstract][Full Text] [Related]
4. Putative genetic deficiency of 4-hydroxyphenylpyruvic acid dioxygenase in mice: a murine model for hereditary tyrosinaemia type III.
Endo F; Katoh H; Matsuda I
J Inherit Metab Dis; 1990; 13(5):780-2. PubMed ID: 2246865
[No Abstract] [Full Text] [Related]
5. [Hereditary tyrosinemia: examination of the liver by electron microscopy of hepatic biopsies: observation of 7 cases].
Tremblay M; Bélanger L; Larochelle J; Privé L; Gagnon PM
Union Med Can; 1977 Jul; 106(7):1014-6. PubMed ID: 898402
[No Abstract] [Full Text] [Related]
6. Urinary excretion of deuterated metabolites in patients with tyrosinemia type I after oral loading with deuterated L-tyrosine.
Wadman SK; Duran M; Ketting D; Bruinvis L; van Sprang FJ; Berger R; Smit GP; Steinmann B; Leonard JV; Divry P; Farriaux JP; Cartigny B
Clin Chim Acta; 1983 May; 130(2):231-8. PubMed ID: 6872257
[TBL] [Abstract][Full Text] [Related]
7. A new variant form of hypertyrosinaemia due to 4-hydroxyphenylpyruvic acid oxidase deficiency.
Endo F; Kitano A; Uehara I; Nagata N; Matsuda I; Shinka T; Kuhara T; Matsumoto I
J Inherit Metab Dis; 1982; 5(4):237-8. PubMed ID: 6133038
[No Abstract] [Full Text] [Related]
8. Hepatic tyrosine aminotransferase in tyrosinaemia type II.
Kida K; Takahashi M; Fujisawa Y; Matsuda H; Machino H; Miki Y
J Inherit Metab Dis; 1982; 5(4):229-30. PubMed ID: 6133036
[No Abstract] [Full Text] [Related]
9. Four-hydroxyphenylpyruvic acid oxidase deficiency with normal fumarylacetoacetase: a new variant form of hereditary hypertyrosinemia.
Endo F; Kitano A; Uehara I; Nagata N; Matsuda I; Shinka T; Kuhara T; Matsumoto I
Pediatr Res; 1983 Feb; 17(2):92-6. PubMed ID: 6828337
[TBL] [Abstract][Full Text] [Related]
10. Enzyme defect in a case of tyrosinemia type I, acute form.
Furukawa N; Kinugasa A; Seo T; Ishii T; Ota T; Machida Y; Inoue F; Imashuku S; Kusunoki T; Takamatsu T
Pediatr Res; 1984 May; 18(5):463-6. PubMed ID: 6145143
[TBL] [Abstract][Full Text] [Related]
11. A murine model for type III tyrosinemia: lack of immunologically detectable 4-hydroxyphenylpyruvic acid dioxygenase enzyme protein in a novel mouse strain with hypertyrosinemia.
Endo F; Katoh H; Yamamoto S; Matsuda I
Am J Hum Genet; 1991 Apr; 48(4):704-9. PubMed ID: 2014797
[TBL] [Abstract][Full Text] [Related]
12. Urinary p-tyramine in hereditary tyrosinemia: I. Levels as compared to normal individuals, effect of diet, and relationship to urinary tyrosine.
Hoag GN; Hill A; Zaleski W
Clin Biochem; 1977 Feb; 10(1):24-5. PubMed ID: 837522
[TBL] [Abstract][Full Text] [Related]
13. [Other abnormalities of tyrosine metabolism].
Endo F
Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):144-5. PubMed ID: 9590010
[No Abstract] [Full Text] [Related]
14. On the enzymic defects in hereditary tyrosinemia.
Lindblad B; Lindstedt S; Steen G
Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4641-5. PubMed ID: 270706
[TBL] [Abstract][Full Text] [Related]
15. Hereditary tyrosinemia type I--an overview.
Kvittingen EA
Scand J Clin Lab Invest Suppl; 1986; 184():27-34. PubMed ID: 3296130
[TBL] [Abstract][Full Text] [Related]
16. A nonsense mutation in the 4-hydroxyphenylpyruvic acid dioxygenase gene (Hpd) causes skipping of the constitutive exon and hypertyrosinemia in mouse strain III.
Endo F; Awata H; Katoh H; Matsuda I
Genomics; 1995 Jan; 25(1):164-9. PubMed ID: 7774914
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene are responsible for tyrosinemia type III and hawkinsinuria.
Tomoeda K; Awata H; Matsuura T; Matsuda I; Ploechl E; Milovac T; Boneh A; Scott CR; Danks DM; Endo F
Mol Genet Metab; 2000 Nov; 71(3):506-10. PubMed ID: 11073718
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the 4-hydroxyphenylpyruvate dioxygenase gene (HPD) in patients with tyrosinemia type III.
Rüetschi U; Cerone R; Pérez-Cerda C; Schiaffino MC; Standing S; Ugarte M; Holme E
Hum Genet; 2000 Jun; 106(6):654-62. PubMed ID: 10942115
[TBL] [Abstract][Full Text] [Related]
19. Parahydroxyphenylpyruvicacidemia in tyrosinosis.
Jaiswal RB; Bhai I; Daginawala HF; Nath N; Nath MC
Indian Pediatr; 1978 Nov; 15(11):893-9. PubMed ID: 36347
[No Abstract] [Full Text] [Related]
20. Promising new treatment for type I tyrosinemia.
Heubi JE
J Pediatr Gastroenterol Nutr; 1993 Oct; 17(3):340-1. PubMed ID: 8271141
[No Abstract] [Full Text] [Related]
[Next] [New Search]
